The Best of Both Worlds

Joshua Robinson, MD, discusses the appeal of private practice for a former …

Read Article
  • From Trials to Treatment:

    A Roundtable Discussion in Medical Retina

    Read Article
  • Diabetes Awareness Month
  • OCT-A Disease Education Resource Center
  • AMD Awareness Month
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • AMD Disease Education Resource Center
  • Articles From This Issue


    The Best of Both Worlds

    Cover Stories: The Turning Point

    The road that brought Joshua Robinson, MD, to private practice at Palmetto Retina Center in West Columbia, S.C. was long and winding. If given the chance, however, he says he …

    Take the Plunge

    Editors’ Message

    Have you ever been out on an open body of water and jumped in? It can be nerve-wracking when you cannot see the bottom -- or anything past the surface, really. The feeling…


    Supplements and Inserts

    High-Speed Cutting: Implications for Tractional Forces

    One of the key components of successful and safe retina surgery is the ability to engage target tissue while causing minimal or no disruption of adjacent tissue. Whether dissecting hyaloid near the retina, peeling a membrane, or performing core vitrectomy, the surgeon must be ever mindful of tractional forces and how much stress the intraocular maneuvers are placing on the retina-vitreous interface.

    A Review of DME Treatment Guidelines and the Role of Early Appropriate Therapy

    The prevalence of diabetes is growing globally; as such the number of people affected by vision-threatening diabetic retinopathy (DR) is likewise expected to continue to increase. Prevent Blindness America has estimated more than 7.6 million people in the United States have DR as a result of their systemic disorder.1

    Retina Surgery Without Compromise

    The majority of my cases are operated using 23-gauge instrumentation using valved cannulas whenever possible. While I do use some 25-gauge, I prefer to use the technology with which I am most comfortable. I am not necessarily resistant to change; however, I have been getting very good results with my particular setup for over a decade, and so it is difficult for me to justify modifying my approach.



    Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of Eylea (aflibercept) Injection for Patients with Wet AMD

    Regeneron announced that the FDA has accepted for review the company's supplemental Biologics License Application (sBLA) for a 12-week dosing interval of Eylea (aflibercept) injection in patients …

    Second Sight Announces Market Entry into Iran with First Two Implants of Argus II Retinal Prosthesis System

    Second Sight Medical Products announced market entry into Iran, implanting the first two patients with the company’s Argus II Retinal Prosthesis System. The implant was facilitated by the countr…

    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Michael Jones
    Senior Editor

    Janet Burk

    About New Retina MD

    New Retina MD delivers cutting-edge content to retina specialists in their first 15 years of practice. Each issue provides fresh insight from younger physicians plus established mentors on clinical and nonclinical issues affecting ophthalmologists in the earlier stages of their careers. NRMD features surgical pearls, clinical research endeavors, practice management, medical reimbursement and policy, continuing educational requirements, financial planning, innovations, and more.